Sign inJoin waitlistJoin the waitlist

Clifton Mo

Director of Autologous Stem Cell Transplantation for Multiple Myeloma · Mass General Brigham

Credentials: · · · · ·

History

Mass General Brigham
Present

Hematology and Medical Oncology
National Capital Consortium
2007–2010
Internal Medicine
Walter Reed National Military Medical Center
2004–2007
Yale School of Medicine
2000–2004

Research

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Journal of Clinical Medicine · 2015 · 106 citations
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation
Blood · 2011 · 90 citations
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study
The Lancet Haematology · 2022 · 84 citations

Paul Richardson
24 papers
Omar Nadeem
14 papers
Jacob Laubach
13 papers
Shonali Midha
11 papers
AS
Adam Sperling
9 papers
Monique Hartley-Brown
9 papers
AY
Andrew Yee
6 papers
Elizabeth O’Donnell
6 papers
Giada Bianchi
6 papers
Yuxin Liu
6 papers
Irene Ghobrial
5 papers
Ken Anderson
5 papers

Clinical trials

D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM
Principal investigator · Not yet recruiting · Phase 3
Dana-Farber Cancer Institute
2026–2038
Marizomib Central Nervous System (CNS)
Principal investigator · Withdrawn · Phase 2
Dana-Farber Cancer Institute
2024–2027
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Site PI · Recruiting · Phase 1, Phase 2
Karyopharm Therapeutics Inc
2015–2027